Amanote Research
Register
Sign In
The Influence of Early Transplantation, Age, GVHD Prevention Regimen, and Other Factors on Outcome of Allogeneic Transplantation for CML Following BuCy
Bone Marrow Transplantation
- United Kingdom
doi 10.1038/sj.bmt.1702689
Full Text
Open PDF
Abstract
Available in
full text
Categories
Transplantation
Hematology
Date
November 1, 2000
Authors
EA Copelan
SL Penza
KS Theil
PJ Elder
TP Bechtel
MB Tighe
SA Ezzone
MD Scholl
PS Belt
DC Young
BR Avalos
Publisher
Springer Science and Business Media LLC
Related search
Prognostic Factors and Outcomes of Severe Gastrointestinal GVHD After Allogeneic Hematopoietic Cell Transplantation
Bone Marrow Transplantation
Transplantation
Hematology
Reconstitution of the CD45RO+ and CD20+ Lymphoid Marrow Population Following Allogeneic Bone Marrow Transplantation for Ph+ CML
Bone Marrow Transplantation
Transplantation
Hematology
Prognostic Factors for Outcomes in Allogeneic Transplantation for CML in the Imatinib Era: A CIBMTR Analysis
Bone Marrow Transplantation
Transplantation
Hematology
Visilizumab With Tacrolimus and Methotrexate for GvHD Prevention After Allogeneic Hematopoietic Cell Transplantation From Mismatched Unrelated Donors
Bone Marrow Transplantation
Transplantation
Hematology
Outcome and Prognostic Factors for Patients Who Relapse After Allogeneic Stem Cell Transplantation.
Blood
Biochemistry
Immunology
Cell Biology
Hematology
CD3+ Graft Cell Count Influence on Chronic GVHD in Haploidentical Allogeneic Transplantation Using Post-Transplant Cyclophosphamide
Bone Marrow Transplantation
Transplantation
Hematology
Influence of Donor Gender in Early Outcome After Lung Transplantation
Critical Care
Critical Care
Intensive Care Medicine
Factors Influencing the Outcome of Renal Transplantation
Japanese Journal of Urology
Urology
Early Allogeneic Transplantation for Refractory or Relapsed Acute Leukaemia Following Remission Induction With FLAG
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
